Showing results (241-250 of 264) with videos related to

Sort By:
Pageof 27
Annals of the Rheumatic Diseases|February 12, 2016
Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysisAlexandre Sepriano, Robert Landewé, Désirée van der Heijde, et al.
Nature Genetics|October 19, 2010
Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasisUlrike Hüffmeier, Steffen Uebe, Arif B Ekici, et al.
Therapeutic Advances in Musculoskeletal Disease|September 11, 2023
Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritisOliver FitzGerald, Frank Behrens, Anne Barton, et al.
Rheumatology (Oxford, England)|January 16, 2023
Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAMSofia Ramiro, Robert Landewé, Désirée van der Heijde, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 4, 2022
Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction ModelingMehreen Soomro, Michael Stadler, Nick Dand, et al.
Arthritis Care & Research|January 29, 2014
Development and testing of new candidate psoriatic arthritis screening questionnaires combining optimal questions from existing toolsLaura C Coates, Jessica Walsh, Muhammad Haroon, et al.
Annals of the Rheumatic Diseases|February 26, 2020
Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM)Sofia Ramiro, Robert Bm Landewé, Désirée van der Heijde, et al.
The Journal of Rheumatology|September 3, 2019
Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RAWalter P Maksymowych, Oliver FitzGerald, Mikkel Østergaard, et al.
Pageof 27